|
AU4525589A
(en)
|
1988-10-27 |
1990-05-14 |
Regents Of The University Of Minnesota |
Liposome immunoadjuvants containing il-2
|
|
JPH03244601A
(ja)
|
1990-02-22 |
1991-10-31 |
Masuko Suzuki |
マンナンと癌細胞分化誘導体の複合体、その製法及び抗癌剤
|
|
US5453491A
(en)
|
1990-09-11 |
1995-09-26 |
Kiyoshi Takatsu |
Murine interleukin-5 receptor
|
|
CA2065658A1
(en)
|
1991-04-19 |
1992-10-20 |
Tse-Wen Chang |
Conjugates of liposomes or microbeads and antibodies specific for t lymphocytes and their use in vivo immune modulators
|
|
US6197298B1
(en)
|
1991-04-19 |
2001-03-06 |
Tanox, Inc. |
Modified binding molecules specific for T lymphocytes and their use as in vivo immune modulators in animals
|
|
ATE260971T1
(de)
|
1992-04-01 |
2004-03-15 |
Univ Rockefeller |
Verfahren zur in vitro kultivierung dendritischer vorläuferzellen und deren verwendung zur immunogen herstellung
|
|
US20020085993A1
(en)
|
1992-11-25 |
2002-07-04 |
Ralph M. Steinman |
Method for in vitro proliferation of dendritic cell precursors and their use to produce immunogens
|
|
US6077519A
(en)
|
1993-01-29 |
2000-06-20 |
University Of Pittsburgh |
Methods for isolation and use of T cell epitopes eluted from viable cells in vaccines for treating cancer patients
|
|
US5753261A
(en)
|
1993-02-12 |
1998-05-19 |
Access Pharmaceuticals, Inc. |
Lipid-coated condensed-phase microparticle composition
|
|
US6180134B1
(en)
|
1993-03-23 |
2001-01-30 |
Sequus Pharmaceuticals, Inc. |
Enhanced ciruclation effector composition and method
|
|
US5464629A
(en)
|
1993-11-16 |
1995-11-07 |
Georgetown University |
Method of forming hydrogel particles having a controlled size using liposomes
|
|
CA2186747C
(en)
|
1994-04-06 |
2009-01-27 |
Kenneth H. Grabstein |
Interleukin-15
|
|
US6548065B1
(en)
|
1994-05-06 |
2003-04-15 |
Immunex Corporation |
Interleukin-15 receptors
|
|
US5591630A
(en)
|
1994-05-06 |
1997-01-07 |
Immunex Corporation |
Monoclonal antibodies that bind interleukin-15 receptors
|
|
EP0772619B2
(en)
|
1994-07-15 |
2010-12-08 |
The University of Iowa Research Foundation |
Immunomodulatory oligonucleotides
|
|
US5795966A
(en)
|
1995-02-22 |
1998-08-18 |
Immunex Corp |
Antagonists of interleukin-15
|
|
WO1996037208A1
(en)
|
1995-05-25 |
1996-11-28 |
Baxter International Inc. |
Allogeneic cell therapy for cancer following allogeneic stem cell transplantation
|
|
WO1997041232A1
(en)
|
1996-04-26 |
1997-11-06 |
Beth Israel Deaconess Medical Center |
Antagonists of interleukin-15
|
|
US6451308B1
(en)
|
1996-04-26 |
2002-09-17 |
Beth Israel Deaconess Medical Center |
Antagonists of interleukin-15
|
|
US6056973A
(en)
|
1996-10-11 |
2000-05-02 |
Sequus Pharmaceuticals, Inc. |
Therapeutic liposome composition and method of preparation
|
|
IN184589B
(ja)
|
1996-10-16 |
2000-09-09 |
Alza Corp |
|
|
US6120751A
(en)
|
1997-03-21 |
2000-09-19 |
Imarx Pharmaceutical Corp. |
Charged lipids and uses for the same
|
|
WO1998053048A1
(en)
|
1997-05-21 |
1998-11-26 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Methods and compositions for making dendritic cells from expanded populations of monocytes and for activating t cells
|
|
WO1999002183A2
(en)
|
1997-07-10 |
1999-01-21 |
Ctl Immunotherapies Corporation |
A method of inducing a ctl response
|
|
US6977074B2
(en)
|
1997-07-10 |
2005-12-20 |
Mannkind Corporation |
Method of inducing a CTL response
|
|
FR2766205B1
(fr)
|
1997-07-16 |
2002-08-30 |
Inst Nat Sante Rech Med |
Nouveau procede de sensibilisation de cellules presentatrices d'antigene et nouveaux moyens pour la mise en oeuvre du procede
|
|
IN190388B
(ja)
|
1997-10-01 |
2003-07-26 |
Biomira Usa Inc |
|
|
US6787132B1
(en)
|
1997-12-04 |
2004-09-07 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Combined chemo-immunotherapy with liposomal drugs and cytokines
|
|
AU2872199A
(en)
|
1998-02-20 |
1999-09-06 |
Rockefeller University, The |
Apoptotic cell-mediated antigen presentation to dendritic cells
|
|
US6693086B1
(en)
|
1998-06-25 |
2004-02-17 |
National Jewish Medical And Research Center |
Systemic immune activation method using nucleic acid-lipid complexes
|
|
US20020001841A1
(en)
|
1998-06-26 |
2002-01-03 |
Keld Kaltoft |
Continuous t-cell lines
|
|
JP2002519019A
(ja)
|
1998-06-26 |
2002-07-02 |
セルキュア アンパーツゼルスカブ |
疾病関連ｔ−細胞の拡張及び選択方法
|
|
EP1101115B1
(en)
|
1998-07-30 |
2004-06-09 |
Oakville Trading Hong Kong Limited |
Method for preparing water-soluble cross-linked conjugates
|
|
US7109003B2
(en)
|
1998-12-23 |
2006-09-19 |
Abgenix, Inc. |
Methods for expressing and recovering human monoclonal antibodies to CTLA-4
|
|
IL129299A0
(en)
|
1999-03-31 |
2000-02-17 |
Mor Research Applic Ltd |
Monoclonal antibodies antigens and diagnosis of malignant diseases
|
|
US6613582B1
(en)
|
1999-05-25 |
2003-09-02 |
Board Of Regents, The University Of Texas System |
Methods for rapid and efficient protein cross-linking
|
|
US6521431B1
(en)
|
1999-06-22 |
2003-02-18 |
Access Pharmaceuticals, Inc. |
Biodegradable cross-linkers having a polyacid connected to reactive groups for cross-linking polymer filaments
|
|
EP1212422B1
(en)
|
1999-08-24 |
2007-02-21 |
Medarex, Inc. |
Human ctla-4 antibodies and their uses
|
|
AU8026800A
(en)
|
1999-10-15 |
2001-04-30 |
Baylor Research Institute |
Use of allogeneic cell lines to load antigen-presenting cells to elicit or eliminate immune responses
|
|
CA3016482A1
(en)
|
1999-11-30 |
2001-06-07 |
Mayo Foundation For Medical Education And Research |
B7-h1, a novel immunoregulatory molecule
|
|
EP1111039A1
(en)
|
1999-12-22 |
2001-06-27 |
Universite Libre De Bruxelles |
Immature autologous clinical grade dendritic cells intended for vaccination of cancer patients
|
|
US6319715B1
(en)
|
2000-04-21 |
2001-11-20 |
Cornell Research Foundation, Inc. |
Method of enhancing the delivery of nucleic acids using silica nanoparticles
|
|
US20020151004A1
(en)
|
2000-07-24 |
2002-10-17 |
Roger Craig |
Delivery vehicles and methods for using the same
|
|
JP4812951B2
(ja)
|
2001-03-21 |
2011-11-09 |
一般財団法人化学及血清療法研究所 |
特異性不明のｔ細胞のクローン化法及びその認識ペプチドリガンドの同定方法
|
|
HUP0303616A3
(en)
|
2001-03-26 |
2006-07-28 |
Alza Corp Mountain View |
Liposome composition for improved intracellular delivery of a therapeutic agent
|
|
EP1390076A4
(en)
|
2001-04-27 |
2004-12-15 |
Xcyte Therapies Inc |
Maturation of antigen-presenting cells with activated cells
|
|
WO2003020884A2
(en)
|
2001-08-14 |
2003-03-13 |
The Government Of The United States Of America As Represented By The Secretary Of Health And Human Services |
Method for rapid generation of mature dendritic cells
|
|
CN1313617C
(zh)
|
2001-11-07 |
2007-05-02 |
曼康公司 |
编码靶相关抗原表位的表达载体及其设计方法
|
|
US20030235619A1
(en)
|
2001-12-21 |
2003-12-25 |
Christine Allen |
Polymer-lipid delivery vehicles
|
|
GB0201679D0
(en)
|
2002-01-25 |
2002-03-13 |
Asterion Ltd |
Polypeptide variants
|
|
AU2003213647A1
(en)
|
2002-02-27 |
2003-09-09 |
Emory University |
Multimeric binding complexes
|
|
AU2003228966C1
(en)
|
2002-05-09 |
2010-05-13 |
Oncothyreon Inc. |
Lipid A and other carbohydrate ligand analogs
|
|
IL149820A0
(en)
|
2002-05-23 |
2002-11-10 |
Curetech Ltd |
Humanized immunomodulatory monoclonal antibodies for the treatment of neoplastic disease or immunodeficiency
|
|
EP3287144A1
(en)
|
2002-07-03 |
2018-02-28 |
ONO Pharmaceutical Co., Ltd. |
Immunopotentiating compositions
|
|
US8034334B2
(en)
|
2002-09-06 |
2011-10-11 |
The United States Of America As Represented By The Secretary, Department Of Health And Human Services |
Immunotherapy with in vitro-selected antigen-specific lymphocytes after non-myeloablative lymphodepleting chemotherapy
|
|
KR101476067B1
(ko)
|
2002-09-06 |
2014-12-23 |
인설트 테라페틱스, 인코퍼레이티드 |
공유결합된 치료제 전달을 위한 사이클로덱스트린-기초 중합체
|
|
NZ539448A
(en)
|
2002-09-20 |
2008-03-28 |
Dendreon Corp |
Immunotherapeutic compositions and methods for the treatment of moderately to well-differentiated prostrate cancers
|
|
US20040057935A1
(en)
|
2002-09-20 |
2004-03-25 |
Cedars-Sinai Medical Center |
Intratumoral delivery of dendritic cells
|
|
WO2004032970A2
(en)
|
2002-10-10 |
2004-04-22 |
Samir Mitragotri |
Carriers attached to blood cells
|
|
BR0315327A
(pt)
|
2002-10-14 |
2005-08-16 |
Hoffmann La Roche |
Antagonistas de il-15
|
|
US8192485B2
(en)
|
2002-11-13 |
2012-06-05 |
The United States of America, as represented by the Department of Veterens Affairs |
Reversible hydrogel systems and methods therefor
|
|
CN101899114A
(zh)
|
2002-12-23 |
2010-12-01 |
惠氏公司 |
抗pd-1抗体及其用途
|
|
US7402431B2
(en)
|
2004-03-01 |
2008-07-22 |
Immunovative Therapies, Ltd. |
T-cell therapy formulation
|
|
US7435592B2
(en)
|
2003-05-13 |
2008-10-14 |
Immunovative Therapies, Ltd. |
Compositions for allogeneic cell therapy
|
|
US20040247624A1
(en)
|
2003-06-05 |
2004-12-09 |
Unger Evan Charles |
Methods of making pharmaceutical formulations for the delivery of drugs having low aqueous solubility
|
|
EP1638993A4
(en)
|
2003-06-10 |
2007-05-09 |
Univ Melbourne |
IMMUNOMODULATING COMPOSITIONS, APPLICATIONS THEREOF AND METHOD FOR THE PRODUCTION THEREOF
|
|
US7223544B2
(en)
|
2003-06-27 |
2007-05-29 |
Cornell Research Foundation, Inc. |
Nucleic acid-engineered materials
|
|
PL1639011T3
(pl)
|
2003-06-30 |
2009-05-29 |
Domantis Ltd |
Pegilowane przeciwciała jednodomenowe (dAb)
|
|
AU2004263094A1
(en)
|
2003-07-09 |
2005-02-17 |
Vaxdesign Corporation |
Programmed immune responses using a vaccination node
|
|
US20050042298A1
(en)
|
2003-08-20 |
2005-02-24 |
Pardridge William M. |
Immunonanoparticles
|
|
US20050123542A1
(en)
|
2003-11-06 |
2005-06-09 |
Genmab A/S |
Methods for treating disorders involving monocytes
|
|
EP1550458A1
(en)
|
2003-12-23 |
2005-07-06 |
Vectron Therapeutics AG |
Synergistic liposomal adjuvants
|
|
EP1705992A1
(en)
|
2004-01-20 |
2006-10-04 |
Cedars-Sinai Medical Center |
Intratumoral delivery of dendritic cells
|
|
JP5744369B2
(ja)
|
2004-02-27 |
2015-07-08 |
アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル |
ＩＬ１５−Ｒα用ＩＬ−１５結合部位およびアゴニスト／アンタゴニスト活性を有する特異的ＩＬ−１５突然変異体
|
|
JP2007526322A
(ja)
|
2004-03-02 |
2007-09-13 |
マサチューセッツ インスティテュート オブ テクノロジー |
ナノセル薬物送達系
|
|
JP2008512350A
(ja)
|
2004-07-01 |
2008-04-24 |
イェール ユニバーシティ |
標的化され、そして高密度で薬物が負荷されるポリマー性物質
|
|
WO2006017853A2
(en)
|
2004-08-11 |
2006-02-16 |
Beth Israel Deaconess Medical Center, Inc. |
Mutant interleukin-15-containing compositions and suppression of an immune response
|
|
TW200616604A
(en)
|
2004-08-26 |
2006-06-01 |
Nicholas Piramal India Ltd |
Nitric oxide releasing prodrugs containing bio-cleavable linker
|
|
US8076132B2
(en)
|
2004-09-17 |
2011-12-13 |
Hasumi International Research Foundation |
Dendritic cell tumor injection (DCTI) therapy
|
|
US20060216269A1
(en)
|
2004-09-17 |
2006-09-28 |
Kenichiro Hasumi |
Dendritic cell tumor injection (DCTI) therapy
|
|
EP1807109A2
(en)
|
2004-10-05 |
2007-07-18 |
Ochsner Clinic Foundation |
Enhancement of b cell proliferation by il-15
|
|
DE102004054536A1
(de)
|
2004-11-06 |
2006-05-11 |
Capsulution Nanoscience Ag |
Multimodal veränderte Zellen als zellulare Darreichungsformen für aktive Substanzen und als diagnostische Zellpartikel
|
|
US7964571B2
(en)
|
2004-12-09 |
2011-06-21 |
Egen, Inc. |
Combination of immuno gene therapy and chemotherapy for treatment of cancer and hyperproliferative diseases
|
|
WO2006127150A2
(en)
|
2005-04-08 |
2006-11-30 |
Argos Therapeutics, Inc. |
Dendritic cell compositions and methods
|
|
US20060257361A1
(en)
|
2005-04-12 |
2006-11-16 |
Government Of The Us, As Represented By The Secretary, Department Of Health And Human Services |
Novel form of interleukin-15, Fc-IL-15, and methods of use
|
|
EP1893241A2
(en)
|
2005-04-28 |
2008-03-05 |
Ventana Medical Systems, Inc. |
Fluorescent nanoparticles conjugated to antibodies via a peg linker
|
|
US8246995B2
(en)
|
2005-05-10 |
2012-08-21 |
The Board Of Trustees Of The Leland Stanford Junior University |
Hydrophobic nanotubes and nanoparticles as transporters for the delivery of drugs into cells
|
|
MX2007014474A
(es)
|
2005-05-17 |
2008-02-07 |
Univ Connecticut |
Composiciones y metodos para inmunomodulacion en un organismo.
|
|
CN104356236B
(zh)
|
2005-07-01 |
2020-07-03 |
E.R.施贵宝&圣斯有限责任公司 |
抗程序性死亡配体1(pd-l1)的人单克隆抗体
|
|
US20070148246A1
(en)
|
2005-08-11 |
2007-06-28 |
Dan Luo |
Nucleic Acid-Based Matrixes
|
|
US20070059318A1
(en)
|
2005-08-15 |
2007-03-15 |
Balu-Iyer Sathy V |
Lipid nano particulates containing antigens as cancer vaccines
|
|
WO2007034479A2
(en)
|
2005-09-20 |
2007-03-29 |
Yissum Research Development Company |
Nanoparticles for targeted delivery of active agents
|
|
EP1777294A1
(en)
|
2005-10-20 |
2007-04-25 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
IL-15Ralpha sushi domain as a selective and potent enhancer of IL-15 action through IL-15Rbeta/gamma, and hyperagonist (IL15Ralpha sushi -IL15) fusion proteins
|
|
TW200800252A
(en)
|
2005-12-08 |
2008-01-01 |
Northwest Biotherapeutics Inc |
Compositions and methods for inducing the activation of immature monocytic dendritic cells
|
|
CN101330923B
(zh)
|
2005-12-12 |
2015-01-07 |
Ac免疫有限公司 |
治疗性疫苗
|
|
PT2347775T
(pt)
|
2005-12-13 |
2020-07-14 |
The President And Fellows Of Harvard College |
Estruturas em andaime para transplante celular
|
|
US20070160578A1
(en)
*
|
2005-12-14 |
2007-07-12 |
The Gov. Of The Usa As Represented By The Secretary Of The Dep. Of Health And Human Services |
Expansion of natural killer and CD8 T-cells with IL-15R/ligand activator complexes
|
|
NZ569541A
(en)
|
2006-01-13 |
2012-05-25 |
Us Gov Health & Human Serv |
Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells
|
|
CN101309705A
(zh)
|
2006-01-13 |
2008-11-19 |
独立行政法人理化学研究所 |
用于免疫疾病的预防或治疗剂以及方法
|
|
EP1987065A4
(en)
|
2006-02-16 |
2010-01-20 |
Nascent Biolog Inc |
METHOD FOR IMPROVING THE IMMUNE FUNCTION AND METHOD FOR PREVENTING OR TREATING DISEASES IN MAMMALS
|
|
US8653238B2
(en)
|
2006-02-27 |
2014-02-18 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compositions and methods for transport of molecules with enhanced release properties across biological barriers
|
|
US20080171059A1
(en)
|
2006-08-07 |
2008-07-17 |
Shanshan Wu Howland |
Methods and compositions for increased priming of t-cells through cross-presentation of exogenous antigens
|
|
EP1921452A1
(en)
|
2006-11-08 |
2008-05-14 |
Medizinische Hochschule Hannover |
Method for the diagnosis of leukemia
|
|
US20080131415A1
(en)
|
2006-11-30 |
2008-06-05 |
Riddell Stanley R |
Adoptive transfer of cd8 + t cell clones derived from central memory cells
|
|
DE102006060824B4
(de)
|
2006-12-21 |
2011-06-01 |
Johannes-Gutenberg-Universität Mainz |
Nachweis von individuellen T-Zell-Reaktionsmustern gegen Tumor-assoziierte Antigene (TAA) in Tumorpatienten als Basis für die individuelle therapeutische Vakzinierung von Patienten
|
|
EP1987839A1
(en)
|
2007-04-30 |
2008-11-05 |
I.N.S.E.R.M. Institut National de la Sante et de la Recherche Medicale |
Cytotoxic anti-LAG-3 monoclonal antibody and its use in the treatment or prevention of organ transplant rejection and autoimmune disease
|
|
US9244059B2
(en)
|
2007-04-30 |
2016-01-26 |
Immutep Parc Club Orsay |
Cytotoxic anti-LAG-3 monoclonal antibody and its use in the treatment or prevention of organ transplant rejection and autoimmune disease
|
|
CA2690825C
(en)
|
2007-05-11 |
2019-02-12 |
Altor Bioscience Corporation |
Fusion molecules and il-15 variants
|
|
NZ599338A
(en)
|
2007-06-27 |
2013-11-29 |
Marinepolymer Tech Inc |
Complexes of il-15 and il-15ralpha and uses thereof
|
|
EP2025746A1
(en)
|
2007-08-16 |
2009-02-18 |
Cell Med Research GMBH |
Dendritic cells
|
|
CA3128656A1
(en)
|
2007-08-22 |
2009-02-26 |
The Regents Of The University Of California |
Activatable binding polypeptides and methods of identification and use thereof
|
|
US8546137B2
(en)
|
2007-09-27 |
2013-10-01 |
The Board Of Trustees Of The University Of Arkansas |
Inhibition of dendritic cell-driven regulatory T cell activation and potentiation of tumor antigen-specific T cell responses by interleukin-15 and MAP kinase inhibitor
|
|
WO2009046738A1
(en)
|
2007-10-09 |
2009-04-16 |
Curevac Gmbh |
Composition for treating lung cancer, particularly of non-small lung cancers (nsclc)
|
|
CA2705797A1
(en)
|
2007-11-14 |
2009-05-22 |
The Regents Of The University Of California |
Sterol-modified amphiphilic lipids
|
|
JP2009149526A
(ja)
|
2007-12-18 |
2009-07-09 |
Tokyo Medical & Dental Univ |
サイトカイン−ナノゲル複合体を含む皮下注射又は筋肉内注射徐放製剤
|
|
WO2009094273A2
(en)
|
2008-01-15 |
2009-07-30 |
Yale University |
Compositions and methods for adoptive and active immunotherapy
|
|
US20110206740A1
(en)
|
2008-04-29 |
2011-08-25 |
Karp Jeffrey M |
Cell Membrane Engineering
|
|
AR072999A1
(es)
|
2008-08-11 |
2010-10-06 |
Medarex Inc |
Anticuerpos humanos que se unen al gen 3 de activacion linfocitaria (lag-3) y los usos de estos
|
|
KR20110074850A
(ko)
|
2008-08-25 |
2011-07-04 |
앰플리뮨, 인크. |
Ｐｄ-１ 길항제 및 그의 사용 방법
|
|
US8323696B2
(en)
|
2008-08-29 |
2012-12-04 |
Ecole Polytechnique Federale De Lausanne |
Nanoparticles for immunotherapy
|
|
CA2736829C
(en)
|
2008-09-12 |
2018-02-27 |
Isis Innovation Limited |
Pd-1 specific antibodies and uses thereof
|
|
AU2009296392B2
(en)
|
2008-09-26 |
2016-06-02 |
Dana-Farber Cancer Institute, Inc. |
Human anti-PD-1, PD-L1, and PD-L2 antibodies and uses therefor
|
|
BRPI0919932A8
(pt)
|
2008-10-24 |
2018-02-06 |
Novartis Ag |
Pirrolina-carbóxi-lisina gerada biossinteticamente, bem como processo para preparar método para derivatizar uma proteína
|
|
WO2010059253A2
(en)
|
2008-11-24 |
2010-05-27 |
Massachusets Institute Of Technology |
Methods and compositions for localized agent delivery
|
|
US8728806B2
(en)
|
2008-12-06 |
2014-05-20 |
The Board Of Regents, The University Of Texas System |
Methods and compositions related to Th-1 dendritic cells
|
|
PE20120341A1
(es)
|
2008-12-09 |
2012-04-24 |
Genentech Inc |
Anticuerpos anti-pd-l1 y su uso para mejorar la funcion de celulas t
|
|
US20100266642A1
(en)
|
2009-02-20 |
2010-10-21 |
Bind Biosciences, Inc. |
Modified cells for targeted cell trafficking and uses thereof
|
|
EP2405758B1
(en)
|
2009-03-09 |
2016-04-27 |
Molecular Express, Inc. |
Methods and compositions for liposomal formulation of antigens and uses thereof
|
|
CN102438936A
(zh)
|
2009-03-09 |
2012-05-02 |
加利福尼亚大学董事会 |
用于具有长期作用的蛋白递送的单蛋白纳米胶囊
|
|
US20110020388A1
(en)
|
2009-05-27 |
2011-01-27 |
Selecta Biosciences, Inc. |
Targeted synthetic nanocarriers with ph sensitive release of immunomodulatory agents
|
|
US20100324124A1
(en)
|
2009-06-17 |
2010-12-23 |
Massachusetts Institute Of Technology |
Compositions and methods relating to DNA-based particles
|
|
US20100323018A1
(en)
|
2009-06-17 |
2010-12-23 |
Massachusetts Institute Of Technology |
Branched DNA/RNA monomers and uses thereof
|
|
US8666674B2
(en)
|
2009-07-28 |
2014-03-04 |
Promising Future, Llc |
Pairing processes for preparing reactive cytotoxic T cells
|
|
US8467973B2
(en)
|
2009-07-28 |
2013-06-18 |
Promising Future, Llc |
Pairing processes for preparing alloreactive cytotoxic T cells
|
|
CA2768965C
(en)
|
2009-08-14 |
2019-06-04 |
George N. Pavlakis |
Use of il-15 to increase thymic output and to treat lymphopenia
|
|
SG178885A1
(en)
|
2009-08-24 |
2012-04-27 |
Baylor College Medicine |
Generation of ctl lines with specificity against multiple tumor antigens or multiple viruses
|
|
US8075895B2
(en)
|
2009-09-22 |
2011-12-13 |
Janssen Pharmaceutica N.V. |
Identification of antigenic peptides from multiple myeloma cells
|
|
KR20120093978A
(ko)
|
2009-10-27 |
2012-08-23 |
이뮤니쿰 에이비 |
항원 특이적 ｔ 세포의 증식 방법
|
|
EP2501413B1
(en)
|
2009-11-18 |
2019-03-27 |
Nektar Therapeutics |
Acid salt forms of polymer-drug conjugates
|
|
WO2011066342A2
(en)
|
2009-11-24 |
2011-06-03 |
Amplimmune, Inc. |
Simultaneous inhibition of pd-l1/pd-l2
|
|
KR101573109B1
(ko)
|
2009-11-24 |
2015-12-01 |
메디뮨 리미티드 |
Ｂ７―ｈ１에 대한 표적화된 결합 물질
|
|
AU2010329805B2
(en)
|
2009-12-11 |
2016-07-14 |
Proyecto De Biomedicina Cima S.L. |
New conjugates and compositions for immunotherapy and anti-tumoral treatment
|
|
CA2791930A1
(en)
|
2010-03-11 |
2011-09-15 |
Kerry Louise Tyson |
Pd-1 antibody
|
|
CA2793604C
(en)
|
2010-03-19 |
2015-10-06 |
Massachusetts Institute Of Technology |
Lipid vesicle compositions and methods of use
|
|
US20110229556A1
(en)
|
2010-03-19 |
2011-09-22 |
Massachusetts Institute Of Technology |
Lipid-coated polymer particles for immune stimulation
|
|
US9149432B2
(en)
|
2010-03-19 |
2015-10-06 |
Massachusetts Institute Of Technology |
Lipid vesicle compositions and methods of use
|
|
KR101846590B1
(ko)
|
2010-06-11 |
2018-04-09 |
교와 핫꼬 기린 가부시키가이샤 |
항 ｔｉｍ-3 항체
|
|
WO2011159877A2
(en)
|
2010-06-18 |
2011-12-22 |
The Brigham And Women's Hospital, Inc. |
Bi-specific antibodies against tim-3 and pd-1 for immunotherapy in chronic immune conditions
|
|
WO2012024396A2
(en)
|
2010-08-17 |
2012-02-23 |
Rutgers, The State University Of New Jersey |
Compositions and methods for delivering nucleic acid molecules and treating cancer
|
|
US9487800B2
(en)
|
2010-09-08 |
2016-11-08 |
Chemotherapeutisches Forschunginstitut Georg-Speyer-Haus |
Interleukin 15 as selectable marker for gene transfer in lymphocytes
|
|
US20130203675A1
(en)
|
2010-09-16 |
2013-08-08 |
Joseph M. DeSimone |
Asymmetric biofunctional silyl monomers and particles thereof as prodrugs and delivery vehicles for pharmaceutical, chemical and biological agents
|
|
KR20140020228A
(ko)
|
2010-09-21 |
2014-02-18 |
알토 바이오사이언스 코포레이션 |
다량체성 아이엘 15 용해성 융합 분자 및 그의 제조 및 사용 방법
|
|
CA2815000A1
(en)
|
2010-10-22 |
2012-04-26 |
Dana-Farber Cancer Institute, Inc. |
Discovery of regulatory t cells programmed to suppress an immune response
|
|
US8741642B2
(en)
|
2010-10-22 |
2014-06-03 |
Virginia Commonwealth University |
Methods for producing autologous immune cells resistant to myeloid-derived suppressor cells effects
|
|
US20140081012A1
(en)
|
2011-02-15 |
2014-03-20 |
The University Of North Carolina At Chapel Hill |
Nanoparticle, liposomes, polymers, agents and proteins modified with reversible linkers
|
|
CN103502439B
(zh)
|
2011-04-13 |
2016-10-12 |
因缪尼卡姆股份公司 |
用于抗原特异性t细胞增殖的方法
|
|
EP2696887A4
(en)
|
2011-04-15 |
2015-01-07 |
Univ California |
POLYMER REDOX REACTION NANOCAPSULES FOR PROTEIN RELEASE
|
|
CA2833636A1
(en)
|
2011-04-20 |
2012-10-26 |
Amplimmune, Inc. |
Antibodies and other molecules that bind b7-h1 and pd-1
|
|
EA027410B1
(ru)
|
2011-04-29 |
2017-07-31 |
Селекта Байосайенсиз, Инк. |
Наноносители, вызывающие иммунную толерантность, для снижения ответной реакции цитотоксических t-лимфоцитов
|
|
CN103906531A
(zh)
|
2011-05-26 |
2014-07-02 |
金纽斯生物科技投资有限责任公司 |
调节的免疫优势疗法
|
|
EP2537933A1
(en)
|
2011-06-24 |
2012-12-26 |
Institut National de la Santé et de la Recherche Médicale (INSERM) |
An IL-15 and IL-15Ralpha sushi domain based immunocytokines
|
|
WO2013006490A2
(en)
|
2011-07-01 |
2013-01-10 |
Cellerant Therapeutics, Inc. |
Antibodies that specifically bind to tim3
|
|
US20130045491A1
(en)
|
2011-07-19 |
2013-02-21 |
Derya Unutmaz |
Methods for activating t cells
|
|
US9511150B2
(en)
|
2011-07-19 |
2016-12-06 |
CellMosaic, Inc. |
Crosslinking reagents, macromolecules, therapeutic bioconjugates, and synthetic methods thereof
|
|
AU2012288413B2
(en)
|
2011-07-24 |
2016-10-13 |
Curetech Ltd. |
Variants of humanized immunomodulatory monoclonal antibodies
|
|
WO2013033430A1
(en)
|
2011-09-02 |
2013-03-07 |
Wake Forest School Of Medicine |
Targeted delivery and prodrug designs for platinum-acridine anti-cancer compounds and methods thereof
|
|
CN103930130B
(zh)
|
2011-09-08 |
2016-07-06 |
耶达研究及发展有限公司 |
抗第三方中央型记忆t细胞、其产生方法以及其在移植和疾病治疗中的应用
|
|
WO2013040371A2
(en)
|
2011-09-16 |
2013-03-21 |
Baylor College Of Medicine |
Targeting the tumor microenvironment using manipulated nkt cells
|
|
LT2785375T
(lt)
|
2011-11-28 |
2020-11-10 |
Merck Patent Gmbh |
Anti-pd-l1 antikūnai ir jų panaudojimas
|
|
AU2012351347B2
(en)
|
2011-12-12 |
2016-05-19 |
Baylor College Of Medicine |
Process of expanding T cells
|
|
GB201121308D0
(en)
|
2011-12-12 |
2012-01-25 |
Cell Medica Ltd |
Process
|
|
KR101680164B1
(ko)
|
2012-02-10 |
2016-11-28 |
하쿠신코우세이카이재단 |
단구 증식제, 단구 증식용 배지, 단구의 제조방법, 수지상 세포의 제조방법, 및 수지상 세포 백신의 제조방법
|
|
JP2013173689A
(ja)
|
2012-02-24 |
2013-09-05 |
Univ Of Tsukuba |
高分子化ニトロキシドラジカル化合物と非ステロイド性抗炎症薬の複合体
|
|
CN115093480A
(zh)
|
2012-05-31 |
2022-09-23 |
索伦托药业有限公司 |
与pd-l1结合的抗原结合蛋白
|
|
US20130337471A1
(en)
|
2012-06-14 |
2013-12-19 |
Emory University |
Cell identification with nanoparticles, compositions and methods related thereto
|
|
US9149535B2
(en)
|
2012-06-28 |
2015-10-06 |
University Of South Carolina |
Polymers and the preparation of nanogel drug cocktails
|
|
UY34887A
(es)
|
2012-07-02 |
2013-12-31 |
Bristol Myers Squibb Company Una Corporacion Del Estado De Delaware |
Optimización de anticuerpos que se fijan al gen de activación de linfocitos 3 (lag-3) y sus usos
|
|
TWI503414B
(zh)
|
2012-07-05 |
2015-10-11 |
Fullhope Biomedical Co Ltd |
一種製備專一性ｔ細胞之配方、方法及其配方製備方法
|
|
US9597356B2
(en)
|
2012-07-05 |
2017-03-21 |
Fullhope Biomedical Co., Ltd |
Method for treating cancers with dendritic killer cells and pharmaceutical composition comprising the same
|
|
TWI458485B
(zh)
|
2012-07-05 |
2014-11-01 |
Fullhope Biomedical Co Ltd |
毒殺型樹突細胞群組用於製備藥物的用途及包含其之醫藥組合物
|
|
US9597383B2
(en)
|
2012-07-05 |
2017-03-21 |
FullHope Biomedical Co., Ltd. |
Formulation and method for preparing specific T cell, and method for preparing the formulation
|
|
ES2848052T3
(es)
|
2012-08-03 |
2021-08-05 |
Dana Farber Cancer Inst Inc |
Anticuerpos de unión dual anti-PD-L1 y PD-L2 de agente individual y métodos de uso
|
|
WO2014055897A2
(en)
|
2012-10-04 |
2014-04-10 |
Dana-Farber Cancer Institute, Inc. |
Human monoclonal anti-pd-l1 antibodies and methods of use
|
|
AU2013334610B2
(en)
|
2012-10-24 |
2018-09-13 |
Novartis Ag |
IL-15R alpha forms, cells expressing IL-15R alpha forms, and therapeutic uses of IL-15R alpha and IL-15/IL-15R alpha complexes
|
|
US9415070B2
(en)
|
2012-11-09 |
2016-08-16 |
Massachusetts Institute Of Technology |
Methods and compositions for localized delivery of agents to virally infected cells and tissues
|
|
AR093984A1
(es)
|
2012-12-21 |
2015-07-01 |
Merck Sharp & Dohme |
Anticuerpos que se unen a ligando 1 de muerte programada (pd-l1) humano
|
|
WO2014127296A1
(en)
|
2013-02-14 |
2014-08-21 |
Immunocellular Therapeutics, Ltd |
Cancer vaccines and vaccination methods
|
|
JP6632072B2
(ja)
|
2013-03-14 |
2020-01-15 |
ザ・ジョンズ・ホプキンス・ユニバーシティー |
ナノスケール人工抗原提示細胞
|
|
AU2014230741B2
(en)
|
2013-03-15 |
2017-04-13 |
Glaxosmithkline Intellectual Property Development Limited |
Anti-LAG-3 binding proteins
|
|
FR3004106B1
(fr)
|
2013-04-05 |
2016-08-05 |
Oreal |
Composition contenant des particules composites filtrant les radiations uv de taille moyenne superieure a 0,1μm et des particules d'aerogel de silice hydrophobes
|
|
DK2986312T3
(da)
|
2013-04-19 |
2022-02-14 |
Cytune Pharma |
Cytokinafledt behandling med reduceret vaskulært lækagesyndrom
|
|
EP2992017B1
(en)
|
2013-05-02 |
2020-11-18 |
AnaptysBio, Inc. |
Antibodies directed against programmed death-1 (pd-1)
|
|
CN105408473B9
(zh)
|
2013-05-14 |
2021-09-17 |
得克萨斯州大学系统董事会 |
工程化嵌合抗原受体(car)t细胞的人应用
|
|
JP6563906B2
(ja)
|
2013-05-31 |
2019-08-21 |
ソレント・セラピューティクス・インコーポレイテッドＳｏｒｒｅｎｔｏ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． |
Ｐｄ−１に結合する抗原結合蛋白質
|
|
WO2014204762A1
(en)
|
2013-06-19 |
2014-12-24 |
Massachusetts Institute Of Technology |
In vivo targeting of cells with ligand-conjugated particles
|
|
WO2014209804A1
(en)
|
2013-06-24 |
2014-12-31 |
Biomed Valley Discoveries, Inc. |
Bispecific antibodies
|
|
US10202433B2
(en)
|
2013-06-27 |
2019-02-12 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
IL-15 mutant polypeptides as IL-15 antagonists and encoding nucleic acids
|
|
KR102457731B1
(ko)
|
2013-08-08 |
2022-10-21 |
싸이튠 파마 |
병용 약학 조성물
|
|
US11273204B2
(en)
|
2013-08-08 |
2022-03-15 |
Cytune Pharma |
IL-15 and IL-15RAPLHA sushi domain based immunocytokines
|
|
WO2015024666A1
(en)
|
2013-08-21 |
2015-02-26 |
Curevac Gmbh |
Composition and vaccine for treating lung cancer
|
|
AU2013400609B9
(en)
|
2013-09-13 |
2020-03-05 |
Beigene Switzerland Gmbh |
Anti-PD1 antibodies and their use as therapeutics and diagnostics
|
|
AU2014324884B2
(en)
|
2013-09-25 |
2020-03-26 |
Cytomx Therapeutics, Inc |
Matrix metalloproteinase substrates and other cleavable moieties and methods of use thereof
|
|
JP7097667B2
(ja)
|
2013-09-27 |
2022-07-08 |
マサチューセッツ インスティテュート オブ テクノロジー |
無担体生物活性タンパク質ナノ構造体
|
|
AU2014339900B2
(en)
|
2013-10-25 |
2019-10-24 |
Dana-Farber Cancer Institute, Inc. |
Anti-PD-L1 monoclonal antibodies and fragments thereof
|
|
CA2929277C
(en)
|
2013-11-01 |
2018-01-16 |
Yale University |
Delivery vehicles comprising il-2 and losartan
|
|
WO2015081158A1
(en)
|
2013-11-26 |
2015-06-04 |
Bristol-Myers Squibb Company |
Method of treating hiv by disrupting pd-1/pd-l1 signaling
|
|
CR20160319A
(es)
|
2013-12-12 |
2016-11-08 |
Jiangsu Hengrui Medicine Co |
Anticuerpo pd-1, fragmento de union al antigeno de este y uso médico de este
|
|
CA2935599A1
(en)
|
2014-01-08 |
2015-07-16 |
Shanghai Hengrui Pharmaceutical Co., Ltd. |
Il-15 heterodimeric protein and uses thereof
|
|
JP2017509319A
(ja)
|
2014-01-15 |
2017-04-06 |
カドモン コーポレイション，リミティド ライアビリティ カンパニー |
免疫調節剤
|
|
TWI681969B
(zh)
|
2014-01-23 |
2020-01-11 |
美商再生元醫藥公司 |
針對ｐｄ-１的人類抗體
|
|
TWI680138B
(zh)
|
2014-01-23 |
2019-12-21 |
美商再生元醫藥公司 |
抗ｐｄ-ｌ１之人類抗體
|
|
EA201691361A1
(ru)
|
2014-01-28 |
2016-12-30 |
Бристол-Маерс Сквибб Компани |
Антитела к lag-3 для лечения гематологических злокачественных опухолей
|
|
EP3105318A1
(en)
|
2014-02-10 |
2016-12-21 |
Nvigen, Inc. |
Cell modulation nanocomposition, and methods of use
|
|
EP2915569A1
(en)
|
2014-03-03 |
2015-09-09 |
Cytune Pharma |
IL-15/IL-15Ralpha based conjugates purification method
|
|
EP3593812A3
(en)
|
2014-03-15 |
2020-05-27 |
Novartis AG |
Treatment of cancer using chimeric antigen receptor
|
|
MA39711A
(fr)
|
2014-04-03 |
2015-10-08 |
Nektar Therapeutics |
Conjugués d'une fraction d'il-15 et d'un polymère
|
|
WO2015179469A2
(en)
|
2014-05-20 |
2015-11-26 |
Kiromic, Llc |
Methods and compositions for treating malignancies with dendritic cells
|
|
CN104189897A
(zh)
|
2014-05-21 |
2014-12-10 |
深圳先进技术研究院 |
一种树突状细胞高效负载抗原的制备方法
|
|
US9885721B2
(en)
|
2014-05-29 |
2018-02-06 |
Spring Bioscience Corporation |
PD-L1 antibodies and uses thereof
|
|
ES2791953T3
(es)
|
2014-06-06 |
2020-11-06 |
Us Health |
Receptores de antígeno quimérico dirigidos a mesotelina y usos de los mismos
|
|
EP3838288A1
(en)
|
2014-06-11 |
2021-06-23 |
polybiocept GmbH |
Expansion of lymphocytes with a cytokine composition for active cellular immunotherapy
|
|
WO2015195163A1
(en)
|
2014-06-20 |
2015-12-23 |
R-Pharm Overseas, Inc. |
Pd-l1 antagonist fully human antibody
|
|
TWI693232B
(zh)
|
2014-06-26 |
2020-05-11 |
美商宏觀基因股份有限公司 |
與pd-1和lag-3具有免疫反應性的共價結合的雙抗體和其使用方法
|
|
WO2016000619A1
(en)
|
2014-07-03 |
2016-01-07 |
Beigene, Ltd. |
Anti-pd-l1 antibodies and their use as therapeutics and diagnostics
|
|
ES2811974T3
(es)
|
2014-07-29 |
2021-03-15 |
Novartis Ag |
Regímenes de aumento escalonado de la dosis del heterodímero de il-15 e il-15ralfa para tratar afecciones
|
|
JO3663B1
(ar)
|
2014-08-19 |
2020-08-27 |
Merck Sharp & Dohme |
الأجسام المضادة لمضاد lag3 وأجزاء ربط الأنتيجين
|
|
SI3186283T1
(sl)
|
2014-08-29 |
2020-04-30 |
F. Hoffmann-La Roche Ag |
Kombinirana terapija z imunocitokini različice IL-2, usmerjenimi proti tumorju in protitelesi proti humanemu PD-L1
|
|
EP3206713A4
(en)
|
2014-10-14 |
2018-06-27 |
Armo Biosciences, Inc. |
Interleukin-15 compositions and uses thereof
|
|
US10272050B2
(en)
|
2014-10-14 |
2019-04-30 |
The Brigham And Women's Hospital, Inc. |
Nanoparticles and methods of use
|
|
US20170333571A1
(en)
|
2014-11-04 |
2017-11-23 |
The Regents Of The University Of California |
Targeted Delivery Platform for Delivery of Therapeutics
|
|
LT3215532T
(lt)
|
2014-11-06 |
2020-01-10 |
F. Hoffmann-La Roche Ag |
Anti-tim3 antikūnai ir jų naudojimo būdai
|
|
TWI595006B
(zh)
|
2014-12-09 |
2017-08-11 |
禮納特神經系統科學公司 |
抗ｐｄ－１抗體類和使用彼等之方法
|
|
CN106459219B
(zh)
|
2014-12-19 |
2019-01-08 |
江苏恒瑞医药股份有限公司 |
白细胞介素15蛋白复合物及其用途
|
|
EP3970748A1
(en)
|
2014-12-24 |
2022-03-23 |
NexImmune, Inc. |
Nanoparticle compositions and methods for immunotherapy
|
|
WO2016111947A2
(en)
|
2015-01-05 |
2016-07-14 |
Jounce Therapeutics, Inc. |
Antibodies that inhibit tim-3:lilrb2 interactions and uses thereof
|
|
US20170151281A1
(en)
|
2015-02-19 |
2017-06-01 |
Batu Biologics, Inc. |
Chimeric antigen receptor dendritic cell (car-dc) for treatment of cancer
|
|
EP3064507A1
(en)
|
2015-03-06 |
2016-09-07 |
Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts |
Fusion proteins comprising a binding protein and an interleukin-15 polypeptide having a reduced affinity for IL15ra and therapeutic uses thereof
|
|
EP3265486A4
(en)
|
2015-03-06 |
2018-11-14 |
Sorrento Therapeutics, Inc. |
Antibody therapeutics that bind tim3
|
|
EP3268012A4
(en)
|
2015-03-12 |
2018-10-31 |
Health Research, Inc. |
Enrichment of cd16+ monocytes to improve dendritic cell vaccine quality
|
|
WO2016145578A1
(en)
|
2015-03-13 |
2016-09-22 |
Syz Cell Therapy Co. |
Methods of cancer treatment using activated t cells
|
|
US20180171294A1
(en)
|
2015-03-26 |
2018-06-21 |
The Trustees Of The University Of Pennsylvania |
In vitro artificial lymph node method for sensitization and expansion of t cells for therapy and epitope mapping
|
|
JP2018510644A
(ja)
|
2015-03-26 |
2018-04-19 |
ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア |
治療およびエピトープマッピング用Ｔ細胞の感作および増殖のためのｉｎ ｖｉｔｒｏ人工リンパ節
|
|
MA41867A
(fr)
|
2015-04-01 |
2018-02-06 |
Anaptysbio Inc |
Anticorps dirigés contre l'immunoglobuline de cellule t et protéine 3 de mucine (tim-3)
|
|
CN116212048A
(zh)
|
2015-08-12 |
2023-06-06 |
麻省理工学院 |
纳米颗粒的细胞表面偶联
|
|
WO2017046200A1
(en)
|
2015-09-16 |
2017-03-23 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Specific interleukin-15 (il-15) antagonist polypeptide and uses thereof for the treatment of inflammatory and auto-immune diseases
|
|
CA2999294A1
(en)
|
2015-09-25 |
2017-03-30 |
Altor Bioscience Corporation |
Interleukin-15 superagonist significantly enhances graft-versus-tumor activity
|
|
AU2016333873A1
(en)
|
2015-10-06 |
2018-05-17 |
The Wistar Institute Of Anatomy And Biology |
Methods and compositions for treatment of metastatic and refractory cancers and tumors
|
|
CN116327903A
(zh)
|
2015-11-20 |
2023-06-27 |
纪念斯隆凯特林癌症中心 |
用于治疗癌症的方法和组合物
|
|
EP3892316A3
(en)
|
2015-12-29 |
2021-11-24 |
Thermogenesis Corp. |
Cell separation devices, systems, and methods
|
|
WO2017205726A1
(en)
|
2016-05-27 |
2017-11-30 |
Altor Bioscience Corporation |
Construction and characterization of multimeric il-15-based molecules with cd3 binding domains
|
|
SG11201903306SA
(en)
|
2016-10-21 |
2019-05-30 |
Altor Bioscience Corp |
Multimeric il-15-based molecules
|
|
EP3678701A4
(en)
|
2017-09-05 |
2021-12-01 |
Torque Therapeutics, Inc. |
THERAPEUTIC PROTEIN COMPOSITIONS AND METHOD FOR MANUFACTURING AND USING THEREOF
|
|
CN113645992A
(zh)
|
2018-11-15 |
2021-11-12 |
转矩医疗股份有限公司 |
用于癌症免疫疗法的方法和组合物
|
|
CA3134817A1
(en)
|
2019-03-29 |
2020-10-08 |
Torque Therapeutics, Inc. |
Immunotherapeutic compositions and use thereof
|